Tag: EGFR TKIs
-
Developments in the Use of EGFR Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
Lung cancer is considered one of the deadliest types of cancer in the world, recording the highest rates of cancer-related deaths. In this context, non-small cell lung cancer (NSCLC) is the most common type, accounting for about 85% of all cases. Over the past decade, treatments related to this disease have shown remarkable progress, particularly…